Position of omalizumab therapy in the treatment of spontaneous chronic urticaria. A case series and literature review

Position of omalizumab therapy in the treatment of spontaneous chronic urticaria. A case series and literature review

Bibliographic Details
Main Authors:	Aleksander Obtułowicz, Magdalena Pirowska, Judyta Maciejowska, Anna Wojas-Pelc
Format:	Article
Language:	English
Published:	Termedia Publishing House 2022-05-01
Series:	Przegląd Dermatologiczny
Subjects:	treatment urticaria omalizumab.
Online Access:	https://www.termedia.pl/Position-of-omalizumab-therapy-in-the-treatment-of-spontaneous-chronic-urticaria-A-case-series-and-literature-review,56,47150,1,1.html

Similar Items

Omalizumab in the treatment of chronic spontaneous urticaria – literature review and own experience
by: Joanna Dawicka, et al.
Published: (2016-02-01)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
by: Öner Özdemir
Published: (2023-08-01)

Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?
by: Thomas B. Casale, MD, et al.
Published: (2024-08-01)

Retrospective analysis of the treatment of 61 cases of chronic spontaneous urticaria with omalizumab
by: Shanshan OU, et al.
Published: (2023-04-01)

Omalizumab for the management of refractory chronic spontaneous urticaria
by: P C Kathuria, et al.
Published: (2022-01-01)

Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years’ Follow-Up: A Case Report
by: Laura Michelina Losappio, et al.
Published: (2020-10-01)

Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
by: Ilya Ivyanskiy, et al.
Published: (2012-01-01)

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
by: Elizabeth García-Gómez, et al.
Published: (2022-05-01)

The use of an urticaria control test for the evaluation of omalizumab treatment response in patients diagnosed with chronic urticaria
by: Burhan Engin, et al.
Published: (2020-12-01)

IgE as a predictor to omalizumab response in patients with chronic spontaneous urticaria
by: Luis Felipe Ensina, et al.
Published: (2025-01-01)

Clinical observation of desloratadine combined with omalizumab in the treatment of chronic spontaneous urticaria
by: Zhiwei SHANG, et al.
Published: (2022-02-01)

Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
by: Anthony F. LaCava, et al.
Published: (2023-08-01)

Treatment of chronic urticaria with omalizumab: the experience of Hospital de Braga
by: Ana G. Lopes, et al.
Published: (2022-10-01)

Progress in the application of omalizumab in the treatment of chronic inducible urticaria
by: CHEN Ziyan, et al.
Published: (2024-12-01)

COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports
by: Angelo Massimiliano D'Erme, et al.
Published: (2023-08-01)

Utilidad clínica del omalizumab en urticaria crónica inducible
by: Ricardo Cardona
Published: (2018-06-01)

Omalizumab for the treatment of chronic spontaneous urticaria: association between body mass index and outcome
by: Irene Russo, et al.
Published: (2022-10-01)

Cold urticaria with risk of anaphylaxis treated with omalizumab: a case report
by: Tonatiuh Ramses Bedolla-Pulido, et al.
Published: (2021-02-01)

Ciclosporina no Tratamento da Urticária Crónica Espontânea na Era do Omalizumab
by: Bárbara Roque Ferreira, et al.
Published: (2018-05-01)

Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients
by: Cristina López, et al.
Published: (2024-08-01)

Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study
by: Vera G. Kalugina, et al.
Published: (2020-08-01)

Omalizumab for treatment of chronic urticaria: A review of effective dose
by: javad Ghaffari, et al.
Published: (2019-03-01)

Treatment of chronic spontaneous urticaria with a single dose of omalizumab: A study of four cases
by: Radhakrishnan Subramaniyan, et al.
Published: (2016-01-01)

The effect of COVID-19 pandemic on treatment compliance and process of chronic urticaria patients receiving omalizumab treatment
by: Gokhan Aytekin, et al.
Published: (2021-09-01)

Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China
by: Ao Wang, MD, et al.
Published: (2022-12-01)

Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients
by: Murat Türk, et al.
Published: (2018-01-01)

Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients
by: Min Jae Kim, et al.
Published: (2023-08-01)

Mapping the intellectual structure of the research of omalizumab in chronic spontaneous urticaria: A bibliometric analysis
by: Yuxu Yao, MD, et al.
Published: (2024-05-01)

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
by: Thomas B. Casale, et al.
Published: (2023-09-01)

Omalizumab withdrawal outcomes in chronic spontaneous urticaria are linked with baseline IgE and eosinophil levels
by: Ramit Maoz-Segal, MD, et al.
Published: (2024-05-01)

Omalizumab for chronic urticaria in Latin America
by: Paul Wilches, et al.
Published: (2016-11-01)

Exploring Machine Learning Techniques to Predict the Response to Omalizumab in Chronic Spontaneous Urticaria
by: Davide Stefano Sardina, et al.
Published: (2021-11-01)

The Role of Bradykinin Receptors in the Etiopathogenesis of Chronic Spontaneous Urticaria
by: Aleksander Obtulowicz, et al.
Published: (2021-10-01)

Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome
by: Chen J, et al.
Published: (2024-08-01)

Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study
by: Michihiro Hide, et al.
Published: (2023-04-01)

Urticaria crónica idiopática o urticaria espontánea y omalizumab. Revisión del tema a propósito de un caso
by: Giovanni Sedó Mejía, et al.
Published: (2014-05-01)

The impact of home treatment and self-administration of omalizumab on chronic urticaria
by: Anne Christine Wiuff, MBBS, et al.
Published: (2022-12-01)

Different doses and courses of omalizumab for patients with chronic spontaneous urticaria: A systematic review with meta-analysis and trial sequential analysis
by: Haiyan Qin, MD, et al.
Published: (2024-04-01)

Long-term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?
by: Özge Kaya, et al.
Published: (2023-07-01)

Changes of Gut Microbiome in Adolescent Patients with Chronic Spontaneous Urticaria After Omalizumab Treatment
by: Wang M, et al.
Published: (2023-02-01)